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Mycobacterium tuberculosis has infected up to one-third of the
global population and remains one of the leading causes of fatal
infections, as the resulting disease is responsible for close to two
million deaths annually.1 The bacterium enters and resides in its
host cell macrophage by subverting phagosomal processing, such
that following engulfment the resulting phagosome compartment
remains at an early endosomal stage rather than maturing into a
bactericidal phagolysosome. Several mechanisms have been pro-
posed for this critical aspect of pathogenesis, and it seems that there
are multiple means by which M. tuberculosis prevents phagosomal
maturation.1
While there is clear evidence that mycobacterial specific cell
surface lipids play a role in the arrest of phagosome maturation,2
that for other effectors remains less definitive, with different genetic
screens indicating roles for nonoverlapping sets of genes. One such
screen, focused on primary effects early in the infection process,
highlighted a role for the product of a five gene operon nominally
involved in isoprenoid biosynthesis, with mutations in the two
unique, presumably nonredundant genes (Rv3377c and Rv3378c)
leading to a significantly decreased ability to prevent phagosomal
maturation.3 Specifically, while phagosomes containing wild type
M. tuberculosis fail to acidify below pH 6.2, those containing the
corresponding mutant mycobacteria acidify to pH 5.7. This more
than 3-fold increase in proton concentration results in a significant
reduction in bacterial proliferation in macrophage cell culture, and
these mutants were among those with the most extreme phenotype,3
indicating that the product of the operon plays a role in the initial
stages of M. tuberculosis entry into macrophages. Later work
demonstrated that the enzyme encoded by the first of these genes,
Rv3377c, acts as a diterpene cyclase that produces bicyclic
halimadienyl diphosphate (1) from the acyclic primary metabolite
(E,E,E)-geranygeranyl diphosphate (GGPP) via a protonation-
initiated (i.e., class II) cyclization mechanism.4
Given the similar phenotypic consequences for mutations in both
Rv3377c, encoding the known class II diterpene cyclase, and the
neighboring Rv3378c, we hypothesized that Rv3378c encodes an
enzyme acting on halimadienyl diphosphate to produce a further
elaborated product. In particular, while Rv3378c is annotated as
encoding a hypothetical protein of unknown function, the translated
sequence contains an aspartate-rich DDXXD divalent metal binding
motif in common with enzymes catalyzing isoprenyl diphosphate
ester cleavage and subsequent carbon-carbon bond formation in
isoprenoid biosynthesis (i.e., isoprenyl diphosphate and class I
terpene synthases, as well as prenyltransferases).5 The purified
recombinant enzymatic gene product of Rv3378c catalyzes just such
a reaction, removing the pyrophosphate group of halimadienyl
diphosphate to specifically form a single diterpene olefin (Figure
S1).6 Further characterization of this enzymatic reaction demon-
strated the expected requirement for the divalent metal ion cofactor
that is typical of isoprenyl diphosphate and class I terpene synthases
(Figure S2).5
Although it was possible to produce and purify ∼250 µg of this
enzymatically generated diterpene through an intensive effort, the
Rv3378c encoded enzyme was found to be unstable in extended
large-scale incubations. Thus, we turned to a biomimetic synthetic
chemical reaction to generate sufficient product for structural
characterization. Specifically, pseudourea-mediated dehydration7 of
the primary alcohol corresponding to hydrolytic dephosphorylation
of 1, which has been termed tuberculosinol (2),4 and is readily
produced by enzymatic dephosphorylation of 1 produced from
GGPP by the Rv3377c encoded enzyme. The chemical reaction
generated several diterpene olefins, with the desired product found
in ∼20% yield (by GC-MS analysis), providing a convenient
semisynthetic route for production of ∼1 mg of pure compound.
Extensive comparison of NMR spectra verified the equivalence of
this semisynthetically produced compound with the enzymatically
generated diterpene.
Upon structural analysis by NMR (Figures S3-5 and Table S1),
this diterpene was found to have a further cyclized (i.e., tricyclic)
hydrocarbon backbone. However, rapid conformational dynamics
of the newly formed ring (relative to 1/2) prevented the acquisition
of NOE data, and thus, it was not possible to definitively assign
the stereochemistry of the geminal methyl-vinyl pair. Formation
of the proposed additional six-carbon ring presumably occurs via
concerted ring closure and deprotonation (Scheme 1). Notably, this
represents a rather unusual terpene cyclization reaction, as these
generally proceed via direct attack of a π bond on the delocalized
allylic carbocation initially formed upon diphosphate ester cleav-
age.5 The resulting diterpene further appears to have a previously
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Scheme 1. Cyclization of 1 to 3 Catalyzed by Rv3378c/MtEDS and
the Corresponding Biomimetic Cyclization of 2 to 3
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unidentified skeletal structure (3), which we propose to name
edaxadiene, from the Latin edaxsdestructive or consuming.
Our results indicate that Rv3378c encodes a halimadienyl
diphosphate (1) specific class I diterpene synthase that produces
edaxadiene (3), and we propose to name this enzyme MtEDS.
However, while this study was in progress, another report was found
suggesting that Rv3378c removed the pyrophosphate group of 1
to form an equal molar mix of tuberculosinol (2) and the related
tertiary alcohol isotuberculosinol,8 although no biological activity
was reported for these compounds, and we found no evidence for
production of either compound with our enzymatic preparations.
To determine if edaxadiene (3) is able to directly affect
phagosomal maturation, the pure compound was tested in bead
based phagocytosis assays (Figure 1).9 While phagosomes formed
with control beads exhibited normal endosomal progression,
including full acidification to pH 4.8, as well as the acquisition of
proteolytic and -galactosidase activity, beads coated with edaxa-
diene exhibited only partial maturation of their phagosome, with
acidification arrested at pH 5.3 and a significant decrease in
proteolytic activity. However, this clearly was a selective rather
than generally toxic effect, as there was very little change in
-galactoside activity. This is consistent with continued accessibility
of M. tuberculosis-containing phagosomes to components of the
early recycling endosomal system.1 Notably, edaxadiene’s effect
on acidification, an increased pH of ∼0.5 units, is comparable to
the effect of mutations in the Rv3377c and Rv3378c/MtEDS genes
on the pH of M. tuberculosis-containing phagosomes, which were
∼0.5 pH units more acidic than those containing wild type bacteria.3
Intriguingly, while MtEDS does contain the previously noted
DDXXD motif, it does not exhibit any other homology to typical
class I terpene synthases (i.e., MtEDS exhibits <10% overall amino
acid sequence identity with any previously identified class I terpene
synthase). Divergence in bacterial class I diterpene synthases has
been previously noted,10 although these are more similar to each
other than MtEDS (g15% identity). Furthermore, despite the lack
of homology between the previously reported class I diterpene
synthases from bacteria, and of those with the better known
eukaryotic terpene synthases, all these contain a conserved
NDX2SX3E motif in addition to the previously noted DDXXD
motif. Indeed, in sequence comparisons of plant, fungal, and
bacterial class I diterpene synthases,11 it is the NDX2SX3E, rather
than DDXXD, motif whose position seems to be better conserved.
Every structurally characterized class I terpene synthase has been
found to utilize both of these motifs in binding a catalytically
requisite trinuclear divalent metal ion cluster, and mutational
analysis has demonstrated that both motifs are critical for class I
terpene synthase activity,5 including seemingly less well conserved
examples in some plant terpene synthases.12 However, in addition
to the distinct lack of sequence identity/similarity to any other
terpene synthase, bacterial or otherwise, MtEDS also does not
contain this second NDX2SX3E divalent metal binding motif (Figure
S6). Nevertheless, MtEDS exhibits a catalytic efficiency equivalent
to that of the other characterized bacterial class I diterpene synthases
(kcat/KM ) 1.1 × 104 M-1 s-1),10,13 including a reasonable affinity
for its substrate (1; KM ) 12 µM; Figure S7). In addition, mutational
analysis demonstrates a catalytic role for the originally noted
DDXXD motif, as alanine substitution for these aspartates reduces
catalytic activity 102-104-fold (Table S2). Thus, MtEDS may
provide an example of extreme divergence from other class I terpene
synthases, although a convergent evolutionary origin cannot be ruled
out.
Regardless of evolutionary origin, the ability of edaxadiene (3)
to directly inhibit endosomal progression presumably contributes
to at least early suppression of phagosome maturation in the
infection process of M. tuberculosis. Thus, it will be of considerable
interest to identify the molecular target of 3 and further characterize
the enzymatic activities involved in its biosynthesis, in particular,
the class II diterpene cyclase encoded by Rv3377c and unusual
class I diterpene synthase encoded by Rv3378c (MtEDS) dedicated
to the production of 3.
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Figure 1. Effect of edaxadiene (3) on phagosomal maturation. Analysis of the kinetics of phagosome maturation determined by ratio fluorometric measurements
of (a) intraphagosomal pH (carboxyfluorescein), (b) intraphagosomal proteolytic activity (DQ Green protease substrate), and (c) intraphagosomal -galactosidase
activity (C12-fluorescein galactopyranoside), following bead uptake (solid lines ) edaxadiene; dashed lines ) control).
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